Parathyroid cancer epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}}; {{AE}} {{Ammu}}
{{CMG}}; {{AE}} {{Ammu}}
==Overview==
==Overview==
The incidence of parathyroid cancer is approximately 0.015 per 100,000 individuals in United States.
The incidence of parathyroid cancer is approximately 0.015 per 100,000 individuals in United States. The female to male ratio is 1 is to 1.
==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Prevalence===
===Prevalence===
Line 12: Line 12:
* The median age in most series is between 45 and 51 years.
* The median age in most series is between 45 and 51 years.
===Gender===
===Gender===
* The ratio of affected women to men is 1:1 in contrast to primary HPT in which there is a significant female predominance (ratio of 3–4:1).
* The ratio of affected female to maile is 1:1.
===Developed Countries===
===Developed Countries===
* In Europe, the United States, and Japan, parathyroid carcinoma has been estimated to cause hyperparathyroidism (HPT) in .017% to 5.2% of the cases; however, many series report this entity to account for less than 1% of patients with primary HPT
* In Europe, the United States, and Japan, parathyroid carcinoma has been estimated to cause hyperparathyroidism (HPT) in .017% to 5.2% of the cases; however, many series report this entity to account for less than 1% of patients with primary HPT

Revision as of 17:57, 23 December 2015

Parathyroid cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Parathyroid cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Parathyroid cancer epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Parathyroid cancer epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Parathyroid cancer epidemiology and demographics

CDC on Parathyroid cancer epidemiology and demographics

Parathyroid cancer epidemiology and demographics in the news

Blogs on Parathyroid cancer epidemiology and demographics

Directions to Hospitals Treating Type chapter name here

Risk calculators and risk factors for Parathyroid cancer epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

The incidence of parathyroid cancer is approximately 0.015 per 100,000 individuals in United States. The female to male ratio is 1 is to 1.

Epidemiology and Demographics

Prevalence

  • In developed countries, the prevalence of parathyroid cancer in United States estimated to be .005%

Incidence

  • In developed countries, the incidence of parathyroid cancer is 0.015 per 100,000 individuals.

Age

  • The median age in most series is between 45 and 51 years.

Gender

  • The ratio of affected female to maile is 1:1.

Developed Countries

  • In Europe, the United States, and Japan, parathyroid carcinoma has been estimated to cause hyperparathyroidism (HPT) in .017% to 5.2% of the cases; however, many series report this entity to account for less than 1% of patients with primary HPT

References


Template:WikiDoc Sources